Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of Mecasin in mild to moderate Alzheimer's disease
KCT0008433Phase 2Not yet recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mecasin in Alzheimer's disease (AD), sponsored by Ministry of Health & Welfare. Planned start May 2023; status: not yet recruiting.
02
Drugs
Mecasin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on KCT0008433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008433.